For example, Interleukin-22 (IL-22), an endogenous cytokine secreted by immune cells, has been shown to correct metabolic reprogramming by maintaining mitochondrial integrity, reducing ROS, and inhibiting lipid accumulation in DKD (Chen et al., 2021; Shen et al., 2021). Here, IL22 is linked to diabetic kidney disease.